These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38302404)

  • 21. Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis.
    Ince B; Işik EG; Özkan ZG; Yalçinkaya Y; Esen BA; Gül A; Inanç M
    Turk J Med Sci; 2024; 54(1):69-75. PubMed ID: 38812633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.
    Owen CE; Poon AMT; Lee ST; Yap LP; Zwar RB; McMenamin CM; Lam SKL; Liew DFL; Pathmaraj K; Kemp A; Scott AM; Buchanan RRC
    Rheumatology (Oxford); 2018 Feb; 57(2):345-353. PubMed ID: 29121248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of
    Moragas Solanes M; Andreu Magarolas M; Martín Miramon JC; Caresia Aróztegui AP; Monteagudo Jiménez M; Oliva Morera JC; Diaz Martín C; Rodríguez Revuelto A; Bravo Ferrer Z; Bernà Roqueta LL
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(5):280-289. PubMed ID: 31126839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patients.
    Nielsen AW; Hansen IT; Nielsen BD; Kjær SG; Blegvad-Nissen J; Rewers K; Sørensen CM; Hauge EM; Gormsen LC; Keller KK
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2614-2624. PubMed ID: 38563881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit.
    Nguyen AD; Crowhurst T; Lester S; Dobson R; Bartholomeusz D; Hill C
    Int J Rheum Dis; 2019 Aug; 22(8):1378-1382. PubMed ID: 31211510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
    Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
    PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients.
    Wendling D; Sondag M; Giraud N; Chouk M; Boulahdour H; Prati C; Verhoeven F
    Joint Bone Spine; 2020 May; 87(3):225-228. PubMed ID: 32007650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study.
    Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D
    Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.
    Blockmans D; Maes A; Stroobants S; Nuyts J; Bormans G; Knockaert D; Bobbaers H; Mortelmans L
    Rheumatology (Oxford); 1999 May; 38(5):444-7. PubMed ID: 10371283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.
    van der Geest KSM; van Sleen Y; Nienhuis P; Sandovici M; Westerdijk N; Glaudemans AWJM; Brouwer E; Slart RHJA
    Rheumatology (Oxford); 2022 Mar; 61(3):1072-1082. PubMed ID: 34117743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
    Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
    Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Sandovici M; Jamar F; Gheysens O; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3886-3902. PubMed ID: 33942141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
    Moya-Alvarado P; Fernandez Leon A; Corica ME; Camacho Marti V; López-Mora DA; Castellví I; Corominas H
    PLoS One; 2021; 16(9):e0255131. PubMed ID: 34559822
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Rehak Z; Sprlakova-Pukova A; Kazda T; Fojtik Z; Vargova L; Nemec P
    Br J Radiol; 2017 Aug; 90(1076):20170198. PubMed ID: 28508663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
    Blockmans D; de Ceuninck L; Vanderschueren S; Knockaert D; Mortelmans L; Bobbaers H
    Arthritis Rheum; 2006 Feb; 55(1):131-7. PubMed ID: 16463425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F-FDG-PET/CT in the evaluation and differential diagnosis of active large-vessel vasculitis. A prospective study].
    Bakos A; Besenyi Z; Sipka G; Urbán S; Hemelein R; Kovács L; Pávics L
    Orv Hetil; 2020 May; 161(20):829-838. PubMed ID: 32364657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis.
    Ikuma D; Sawa N; Yamanouchi M; Oba Y; Mizuno H; Suwabe T; Hoshino J; Ubara Y
    Mod Rheumatol; 2024 Mar; 34(3):474-478. PubMed ID: 37279960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in Diagnosing Polymyalgia Rheumatica and Large-Vessel Vasculitis: A Case-Control Study.
    Desvages A; Hives F; Deprez X; Pierache A; Béhal H; Flipo RM; Paccou J
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.